Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 855

BillFederalSenateFloor Consideration
Royalty Transparency Act
About This Bill
Introduced
Latest Action · September 17, 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 165.
Congress
119th (2025–2027)
Introduced
March 5, 2025
Sponsor
Sen. Rand PaulR
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
This bill requires federal executive branch employees and members of certain health advisory committees to publicly disclose any royalties they receive from inventions they developed while working for the government. The legislation affects employees at agencies like NIH, CDC, and FDA, as well as members of advisory committees such as those that make vaccine recommendations or advise on biosecurity issues. These employees must report the source and amount of any royalty payments they or their families receive, and agencies must publish this information on their websites and provide unredacted copies to Congress within 30 days of a request. The bill also requires federal agencies to review potential conflicts of interest involving royalty payments when awarding contracts or grants, with annual reports to Congress on any conflicts identified. The disclosure requirements take effect 60-180 days after enactment, with some provisions automatically expiring after five years.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.